Skip to content

Shares (Basic) at other companies

Eli Lilly logo
Eli LillyLLY
894.5M-0.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.1%
Amgen logo
AmgenAMGN
540M+0.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
104M-2.5%
Janux Therapeutics logo
Janux TherapeuticsJANX
62.7M+1.4%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
24.7M+75.9%

Other financials

Income statement

See full
Revenue-
Operating income-$53.7M+2.4%
Net income-$49.7M-2.4%
EPS (diluted)-$0.69+24.2%

Balance sheet

See full
Cash & equivalents$75.1M-2.1%
Total debt$2.4M+29.5%
Total equity$408.7M-30.8%
Total assets$403.0M-30.5%

Cash flow

See full
Operating cash flow-$46.0M-6.7%
CapEx$11.0K
Free cash flow-$38.1M-4.1%

Valuation

See full
Market cap$1.08B+140%
Enterprise value$1.01B+168%

Profitability

See full
Operating margin-358.7%
Net margin-346.1%

Returns & leverage

See full
Return on equity-44%+26.2pp
Debt / equity0.0×
Current ratio10.3×-1.3×

Where this comes from

Reported directly by Cullinan Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed November 7, 2024, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s shares (basic)?
Cullinan Therapeutics, Inc. (CGEM) reported shares (basic) of 58.3M in Q3 2024.
How has Cullinan Therapeutics, Inc.'s shares (basic) changed year-over-year?
Cullinan Therapeutics, Inc.'s shares (basic) increased by 36.5% year-over-year, from 42.7M to 58.3M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.